An analysis of Medicaid data of the 60 most popular psychiatric drugs found a hike in medications for depression, anxiety and attention-deficit/hyperactivity disorder. Prescriptions for sertraline, the generic for Zoloft and most common antidepressant, rose 17% in those three years.
Before the COVID-19 pandemic, the utilization of mental health therapies were on the rise, but the pandemic accelerated the trend. According to a recent Census Bureau survey, the percentage of people experiencing anxiety or depression is double prepandemic levels.
